Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00266266 · ClinicalTrials.gov registry record
Human Papilloma Virus DNA Self-Test
A clinical trial, sponsored by University of Louisville.
- Completed
- Registry status
- 171
- Enrollment target
NCT00266266: Completed study, sponsored by University of Louisville.
NCT00266266 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 171 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00266266 has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 171 participants
- Enrollment target
Study Summary
HPV DNA testing by a clinician has been shown to be highly sensitive in detecting cervical disease. Can we prove that HPV self-testing will be sufficiently sensitive to detect disease in high risk population who for various reasons would not have routine pap smear screening?
Primary Outcome
To assess the concordance of HPV DNA self-testing device to detect disease in patients with abnormal Pap smear. Patients with a positive HPV Self-test by vaginal swab or vaginal tampon will be compared to the physician test results for concordance. Following patient self-sample collection, physician will collect cervical samples using a spatula. A self testing device which patients can use at their convenience will be beneficial in decreasing the incidence of cervical cancer in Kentucky.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2004-01 |
| Est. Completion | 2008-10 |
What the finished NCT00266266 record still lists
NCT00266266 is an observational study that tracks outcomes without assigning an intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00266266 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00266266 about?
NCT00266266 is a clinical study titled "Human Papilloma Virus DNA Self-Test". HPV DNA testing by a clinician has been shown to be highly sensitive in detecting cervical disease. Can we prove that HPV self-testing will be sufficiently sensitive to detect disease in high risk population who for various reasons would not have routine pap smear screening?
What is the current status of trial NCT00266266?
This trial is currently completed. The enrollment target is 171 participants. The study started on 2004-01. Estimated completion is 2008-10.
Who is sponsoring clinical trial NCT00266266?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02641145 · 171 participants · NA
Molecular Imaging of Primary Amyloid Cardiomyopathy
- NCT05541029 · 171 participants · NA
Music Listening: A Mechanistic Trial
- NCT05561127 · 171 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
- NCT05592938 · 171 participants · NA
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia